Trial Profile
Reduction of Tacrolimus With Everolimus Addition in Maintenance Immunosuppression in Patients with Kidney Allografts and Calcineurin Inhibitor-induced Arteriolopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- 20 Aug 2015 New trial record